Short‐term dual antiplatelet therapy in diabetic patients admitted for acute coronary syndrome treated with a new‐generation drug‐eluting stent

BACKGROUND: The optimal duration of dual antiplatelet therapy (DAPT) in patients with diabetes mellitus (DM) admitted with acute coronary syndrome (ACS) and treated with a drug‐eluting stent (DES) remains unclear. This is a prespecified sub‐study from the Randomised Evaluation of short‐term DUal ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Vranken, Nousjka P. A., Rasoul, Saman, Luijkx, Jasper J. P., Pustjens, Tobias F. S., Postma, Sonja, Kolkman, Evelien J., Kedhi, Elvin, Rifqi, Sodiqur, Lee, Michael K. Y., Ebelt, Henning, Merkely, Béla, Verdoia, Monica, Wojakowski, Wojtek, van ’t Hof, Arnoud A. W. J., Suryapranata, Harry, De Luca, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541907/
https://www.ncbi.nlm.nih.gov/pubmed/35395144
http://dx.doi.org/10.1002/dmrr.3530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541907/
https://www.ncbi.nlm.nih.gov/pubmed/35395144
http://dx.doi.org/10.1002/dmrr.3530

Ejemplares similares